Literature DB >> 14522856

Immune system and peripheral nerves in propagation of prions to CNS.

Adriano Aguzzi1, Frank L Heppner, Mathias Heikenwalder, Marco Prinz, Kirsten Mertz, Harald Seeger, Markus Glatzel.   

Abstract

Prions are not only unique in the way they replicate. Also the sequence of events triggered by peripheral prion infection, generically termed 'peripheral pathogenesis', sets prions aside from all other known pathogens. Whereas most bacteria, parasites, and viruses trigger innate and adaptive immune responses, the mammalian immune system appears to be remarkably oblivious to prions. Transmissible spongiform encephalopathies (TSEs) do not go along with inflammatory infiltrates, and antibodies to the prion protein are not typically raised during the course of the disease. On the other hand, there is conspicuous involvement of lymphoid organs, which accumulate sizeable concentrations of the infectious agent early during disease. Moreover, various states of immune deficiency can abolish peripheral pathogenesis and prevent 'take' of infection when prions are administered to peripheral sites. Here, we critically re-visit the current evidence for an involvement of the immune system in prion diseases, and will attempt to trace the elaborate mechanisms by which prions, upon entry into the body from peripheral sites, reach the brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522856     DOI: 10.1093/bmb/66.1.141

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  19 in total

1.  Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations.

Authors:  Carole Crozet; Yea-Lih Lin; Clément Mettling; Chantal Mourton-Gilles; Pierre Corbeau; Sylvain Lehmann; Véronique Perrier
Journal:  J Cell Sci       Date:  2004-10-19       Impact factor: 5.285

2.  Temporary depletion of CD11c+ dendritic cells delays lymphoinvasion after intraperitonal scrapie infection.

Authors:  Sevda Cordier-Dirikoc; Joëlle Chabry
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

3.  The normal cellular prion protein (PrPc) is strongly expressed in bovine endocrine pancreas.

Authors:  W M Amselgruber; M Büttner; T Schlegel; M Schweiger; E Pfaff
Journal:  Histochem Cell Biol       Date:  2005-10-06       Impact factor: 4.304

4.  Initial fate of prions upon peripheral infection: half-life, distribution, clearance, and tissue uptake.

Authors:  Akihiko Urayama; Rodrigo Morales; Michael L Niehoff; William A Banks; Claudio Soto
Journal:  FASEB J       Date:  2011-05-09       Impact factor: 5.191

5.  The sheddase ADAM10 is a potent modulator of prion disease.

Authors:  Hermann C Altmeppen; Johannes Prox; Susanne Krasemann; Berta Puig; Katharina Kruszewski; Frank Dohler; Christian Bernreuther; Ana Hoxha; Luise Linsenmeier; Beata Sikorska; Pawel P Liberski; Udo Bartsch; Paul Saftig; Markus Glatzel
Journal:  Elife       Date:  2015-02-05       Impact factor: 8.140

6.  Developmental expression of the cellular prion protein (PrP(C) ) in bovine embryos.

Authors:  Oscar A Peralta; William R Huckle; Willard H Eyestone
Journal:  Mol Reprod Dev       Date:  2012-07       Impact factor: 2.609

Review 7.  Immunotherapy in prion disease.

Authors:  Yvonne Roettger; Yansheng Du; Michael Bacher; Inga Zerr; Richard Dodel; Jan-Philipp Bach
Journal:  Nat Rev Neurol       Date:  2012-12-18       Impact factor: 42.937

8.  Neuroinvasion in prion diseases: the roles of ascending neural infection and blood dissemination.

Authors:  Sílvia Sisó; Lorenzo González; Martin Jeffrey
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-06-23

9.  Mouse-adapted scrapie infection of SN56 cells: greater efficiency with microsome-associated versus purified PrP-res.

Authors:  Gerald S Baron; Ana C Magalhães; Marco A M Prado; Byron Caughey
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

10.  Rapamycin delays disease onset and prevents PrP plaque deposition in a mouse model of Gerstmann-Sträussler-Scheinker disease.

Authors:  Constanza J Cortes; Kefeng Qin; Julie Cook; Ani Solanki; James A Mastrianni
Journal:  J Neurosci       Date:  2012-09-05       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.